Your browser is no longer supported. Please, upgrade your browser.
Settings
RMD ResMed Inc. daily Stock Chart
RMD [NYSE]
ResMed Inc.
IndexS&P 500 P/E34.29 EPS (ttm)2.47 Insider Own0.90% Shs Outstand142.49M Perf Week1.89%
Market Cap12.06B Forward P/E25.08 EPS next Y3.37 Insider Trans-24.04% Shs Float140.24M Perf Month7.41%
Income352.30M PEG3.38 EPS next Q0.77 Inst Own65.80% Short Float5.73% Perf Quarter15.24%
Sales2.12B P/S5.68 EPS this Y-3.50% Inst Trans3.25% Short Ratio13.05 Perf Half Y21.75%
Book/sh14.41 P/B5.87 EPS next Y10.77% ROA10.30% Target Price72.10 Perf Year43.95%
Cash/sh5.69 P/C14.87 EPS next 5Y10.15% ROE18.60% 52W Range57.45 - 87.81 Perf YTD36.39%
Dividend1.40 P/FCF54.05 EPS past 5Y7.10% ROI11.40% 52W High-3.62% Beta0.79
Dividend %1.65% Quick Ratio3.90 Sales past 5Y8.60% Gross Margin58.30% 52W Low47.31% ATR1.59
Employees6080 Current Ratio4.70 Sales Q/Q12.50% Oper. Margin20.90% RSI (14)64.08 Volatility1.74% 2.12%
OptionableYes Debt/Eq0.00 EPS Q/Q12.10% Profit Margin16.60% Rel Volume0.75 Prev Close84.98
ShortableYes LT Debt/Eq0.50 EarningsOct 26 AMC Payout53.90% Avg Volume615.98K Price84.63
Recom3.00 SMA202.62% SMA506.04% SMA20013.51% Volume459,413 Change-0.41%
Sep-25-17Reiterated Barclays Underweight $65 → $68
Aug-02-17Upgrade Citigroup Neutral → Buy
Aug-02-17Downgrade Credit Suisse Outperform → Neutral
Aug-02-17Downgrade BofA/Merrill Buy → Neutral
Apr-28-17Downgrade Citigroup Buy → Neutral
Jan-24-17Upgrade JP Morgan Neutral → Overweight
Jan-24-17Reiterated Canaccord Genuity Hold $55 → $59
Oct-04-16Initiated JP Morgan Neutral $64
Aug-23-16Downgrade Jefferies Hold → Underperform
Jun-27-16Downgrade Needham Hold → Underperform
Apr-28-16Upgrade Macquarie Underperform → Neutral
Apr-27-16Downgrade Piper Jaffray Overweight → Neutral
Apr-07-16Resumed Barclays Underweight $55
Jan-22-16Upgrade Credit Suisse Neutral → Outperform
Jan-19-16Downgrade Barclays Equal Weight → Underweight $61 → $52
Dec-17-15Downgrade Needham Buy → Hold
Jul-13-15Downgrade Macquarie Neutral → Underperform
Jun-25-15Initiated Barclays Equal Weight $61
May-14-15Reiterated Needham Buy $77 → $65
May-13-15Downgrade BofA/Merrill Buy → Neutral
Nov-18-17 11:32AM  3 Top Medical Device Stocks to Buy Now Motley Fool
Nov-17-17 09:00AM  ResMed Elects Karen Drexler to Its Board of Directors CNW Group
Nov-13-17 01:07PM  ETFs with exposure to ResMed, Inc. : November 13, 2017 Capital Cube
Nov-12-17 08:51PM  Statement by ResMed on United Kingdom Case with Fisher & Paykel PR Newswire
05:16PM  Fisher & Paykel says UK court rules rival Resmed's patent is invalid Reuters
04:42PM  Statement by ResMed on United Kingdom Case with Fisher & Paykel PR Newswire
Nov-10-17 07:01PM  Lifshitz & Miller LLP Announces Investigation of Calpine Corporation, Deltic Timber Corporation, FactSet Research Systems Inc., Intel Corporation, Norwegian Cruise Line Holdings Ltd., ResMed Inc. and Tyler Technologies, Inc. PR Newswire
09:00AM  SleepScore Labs Launches the World's Most Advanced Sleep Improvement System PR Newswire
Nov-06-17 01:14PM  Companies are using ghost revenue to calculate executive bonuses MarketWatch
09:00AM  ResMed Adds Remote Patient Monitoring to AirMini, World's Smallest CPAP PR Newswire
Nov-03-17 08:49PM  Read This Before Buying ResMed Inc (RMD) For Its Upcoming $0.35 Dividend Simply Wall St.
Nov-02-17 12:31PM  ETFs with exposure to ResMed, Inc. : November 2, 2017 Capital Cube
08:05AM  See what the IHS Markit Score report has to say about ResMed Inc. Markit
Nov-01-17 09:34AM  ResMed, Inc. :RMD-US: Earnings Analysis: Q1, 2018 By the Numbers : November 1, 2017 Capital Cube
Oct-30-17 08:23AM  ResMed's Sales and Profits Rise Motley Fool
03:00AM  Resmed Meets 80-Plus Relative Strength Rating Benchmark Investor's Business Daily
Oct-28-17 08:11AM  Edited Transcript of RMD earnings conference call or presentation 26-Oct-17 8:30pm GMT Thomson Reuters StreetEvents
Oct-27-17 04:03PM  Here's Why ResMed Inc. Stock Spiked Today Motley Fool +7.39%
09:22AM  ResMed (RMD) Q1 Earnings Top on Growth in All Business Lines Zacks
Oct-26-17 04:51PM  ResMed beats 1Q profit forecasts Associated Press
04:05PM  ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2018 PR Newswire
08:08AM  See what the IHS Markit Score report has to say about ResMed Inc. Markit
Oct-25-17 09:52AM  MedTech Stock Q3 Earnings Roster for Oct 26: BSX, RMD & More Zacks
Oct-16-17 10:14AM  Can ResMed (RMD) Maintain Balanced Growth in Q1 Earnings? Zacks
09:59AM  ETFs with exposure to ResMed, Inc. : October 16, 2017 Capital Cube
Oct-12-17 10:12AM  ResMed Wins German Patent Infringement Case Brought by Fisher & Paykel PR Newswire
09:45AM  ResMed Wins German Patent Infringement Case Brought by Fisher & Paykel CNW Group
Oct-10-17 08:26AM  ResMed, Inc. breached its 50 day moving average in a Bearish Manner : RMD-US : October 10, 2017 Capital Cube
Oct-09-17 08:05AM  See what the IHS Markit Score report has to say about ResMed Inc. Markit
07:20AM  Corporate News Blog - German Court Stays Infringement Proceedings Against Fisher & Paykel In ResMed Patent Infringement Case ACCESSWIRE
Oct-06-17 08:06AM  See what the IHS Markit Score report has to say about ResMed Inc. Markit
05:36AM  ResMed's European Patents Infringed by Fisher & Paykel in Germany PR Newswire
04:52AM  ResMed's European Patents Infringed by Fisher & Paykel in Germany PR Newswire
Oct-05-17 08:05AM  See what the IHS Markit Score report has to say about ResMed Inc. Markit
Oct-04-17 08:07AM  See what the IHS Markit Score report has to say about ResMed Inc. Markit
Oct-03-17 11:33AM  ETFs with exposure to ResMed, Inc. : October 3, 2017 Capital Cube
Oct-02-17 08:58AM  ResMed, Inc. :RMD-US: Earnings Analysis: Q4, 2017 By the Numbers : October 2, 2017 Capital Cube
08:06AM  See what the IHS Markit Score report has to say about ResMed Inc. Markit
Sep-28-17 06:14PM  German court suspends Resmed's complaint against NZ's Fisher & Paykel Reuters
05:01PM  German court suspends Resmed's complaint against NZ's Fisher & Paykel Reuters
04:05PM  ResMed to Announce First Quarter Fiscal Year 2018 Results PR Newswire
10:29AM  ResMed, Inc. Value Analysis (NYSE:RMD) : September 28, 2017 Capital Cube
Sep-27-17 08:18AM  ResMed, Inc. breached its 50 day moving average in a Bearish Manner : RMD-US : September 27, 2017 Capital Cube
08:05AM  See what the IHS Markit Score report has to say about ResMed Inc. Markit
Sep-18-17 08:32AM  UBS has a playbook for New Zealands knife-edge election CNBC
08:05AM  See what the IHS Markit Score report has to say about ResMed Inc. Markit
Sep-14-17 08:06AM  See what the IHS Markit Score report has to say about ResMed Inc. Markit
Sep-13-17 08:06AM  See what the IHS Markit Score report has to say about ResMed Inc. Markit
Sep-12-17 08:06AM  See what the IHS Markit Score report has to say about ResMed Inc. Markit
06:00AM  Automated Resupply Enrollment Now Available for HMEs Using Brightree and ResMeds AirView Business Wire
Sep-11-17 10:11AM  See what the IHS Markit Score report has to say about ResMed Inc. Markit
06:22AM  Why Is ResMed (RMD) Up 3.1% Since the Last Earnings Report? Zacks
Sep-08-17 03:00AM  Resmed Meets 80-Plus Relative Strength Rating Benchmark Investor's Business Daily
Sep-01-17 10:11AM  ResMed, Inc. breached its 50 day moving average in a Bullish Manner : RMD-US : September 1, 2017 Capital Cube
Aug-22-17 08:06AM  See what the IHS Markit Score report has to say about ResMed Inc. Markit
Aug-18-17 05:57PM  ETFs with exposure to ResMed, Inc. : August 18, 2017 Capital Cube
Aug-16-17 08:00AM  3 Dividend Healthcare Stocks Motley Fool
07:10AM  Earnings Review and Free Research Report: ResMed Adjusted Diluted EPS Increased 4% ACCESSWIRE
Aug-14-17 08:06AM  See what the IHS Markit Score report has to say about ResMed Inc. Markit
Aug-12-17 11:25PM  Edited Transcript of RMD earnings conference call or presentation 1-Aug-17 8:30pm GMT Thomson Reuters StreetEvents
08:05AM  See what the IHS Markit Score report has to say about ResMed Inc. Markit
Aug-11-17 07:10AM  Corporate News Blog - Bionix(R) Radiation Therapy Signs on Varian Medical Systems as Distributor for its Brachytherapy Applicators ACCESSWIRE
Aug-07-17 02:57PM  ResMed, Inc. :RMD-US: Earnings Analysis: 2017 By the Numbers : August 7, 2017 Capital Cube
Aug-03-17 09:52AM  ResMed, Inc. breached its 50 day moving average in a Bearish Manner : RMD-US : August 3, 2017 Capital Cube
09:01AM  ResMed Tops Expectations but Falls Anyway Motley Fool
Aug-02-17 09:39AM  ResMed (RMD) Q4 Earnings Top, 2020 Strategic Goals on Track Zacks -6.41%
Aug-01-17 09:55PM  ResMed beats 4Q profit forecasts Associated Press
04:05PM  ResMed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2017 PR Newswire
Jul-31-17 10:19AM  Medical Products Earnings Due on Aug 1: IDXX, RMD Zacks
Jul-21-17 09:21AM  Is a Surprise in Store for ResMed (RMD) in Q4 Earnings? Zacks
Jul-19-17 05:49PM  MGM Resorts, ResMed, Packaging Corporation of America, A.O. Smith and Duke Realty Set to Join S&P 500; Others to Join S&P MidCap 400 PR Newswire
Jul-12-17 10:20AM  Here's Why You Should Add ResMed to Your Portfolio Now Zacks
Jul-07-17 09:15AM  ResMed Sees Potential in SDB Market, Eyes Global Growth Zacks
Jul-06-17 05:30PM  Top Leadership of ViaSat, ResMed, Qualcomm, DLA Piper join EvoNexus Board of Directors PR Newswire
Jun-29-17 04:05PM  ResMed to Announce Fourth Quarter Fiscal Year 2017 Results PR Newswire
Jun-20-17 09:28AM  ResMed (RMD) at 52-Week High: What's Driving the Stock? Zacks
Jun-14-17 02:26PM  Which Stocks Are Showing Rising Relative Strength? Investor's Business Daily
11:53AM  Sleep Apnea Treatment Provider Enters New Buy Zone Investor's Business Daily
Jun-09-17 03:35PM  FDA Approval Boosts Baxters Generic Injectable Business Market Realist
May-31-17 04:12AM  Why Is ResMed (RMD) Down 3.8% Since the Last Earnings Report? Zacks
May-25-17 12:47PM  ETFs with exposure to ResMed, Inc. : May 25, 2017 Capital Cube
May-22-17 09:15AM  Big Data Yields Big Insights for Treatment of Central Sleep Apnea PR Newswire
May-21-17 10:04AM  Clinical Trial Published in JAMA Offers New Hope for COPD Patients PR Newswire
May-17-17 04:22AM  Statement by ResMed on Plans to Renew Its Patent Infringement Case Against Fisher & Paykel PR Newswire
May-16-17 08:13PM  ResMed withdraws U.S. trade complaint against Fisher & Paykel Healthcare Reuters
09:00AM  Introducing the Softest CPAP Mask from ResMed PR Newswire
May-08-17 09:01PM  Edited Transcript of RMD earnings conference call or presentation 27-Apr-17 8:30pm GMT Thomson Reuters StreetEvents
May-04-17 09:30AM  Why Motley Fool Co-Founder David Gardner Likes ResMed Inc. Motley Fool
May-02-17 04:33PM  ETFs with exposure to ResMed, Inc. : May 2, 2017 Capital Cube
May-01-17 10:44AM  ResMed, Inc. :RMD-US: Earnings Analysis: Q3, 2017 By the Numbers : May 1, 2017 Capital Cube
09:04AM  Acquisitions Help Drive ResMed's Revenue 13% Higher Motley Fool
Apr-28-17 05:11PM  ResMed, Inc. Value Analysis (NYSE:RMD) : April 28, 2017 Capital Cube -6.67%
10:55AM  ResMed (RMD) Beats Q3 Earnings, Misses Sales Estimates Zacks
Apr-27-17 06:02PM  ResMed tops 3Q profit forecasts Associated Press
04:05PM  ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2017 PR Newswire
08:35AM  ResMed, Inc. breached its 50 day moving average in a Bullish Manner : RMD-US : April 27, 2017 Capital Cube
Apr-26-17 08:19AM  Medical Product Stocks' Earnings on Apr 27: ZBH, RMD & More Zacks
Apr-25-17 09:39AM  ResMed Unveils AirMini - the World's Smallest CPAP PR Newswire
09:19AM  ResMed Unveils AirMini - the World's Smallest CPAP CNW Group
Apr-18-17 09:27AM  ResMed (RMD) Q3 Earnings: Disappointment in the Cards? Zacks
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications that diagnose, treat, and manage respiratory disorders comprising sleep disordered breathing, chronic obstructive pulmonary disease, neuromuscular disease, and other chronic diseases. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, portable oxygen concentrators, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides humidifiers, carry bags, and breathing circuits; and data communications and control products, such as EasyCare, ResLink, ResControl, ResControl II, TxControl, ResScan, and ResTraxx modules that facilitate the transfer of data and other information to and from the flow generators. It markets its products to sleep clinics, home healthcare dealers, patients, hospitals, physicians, and third-party payers through a network of distributors and direct sales force in approximately 120 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
FARRELL PETER CDirectorNov 09Option Exercise35.33118,3924,182,295413,192Nov 13 05:42 PM
FARRELL PETER CDirectorNov 09Sale82.70118,3929,791,100294,800Nov 13 05:42 PM
FARRELL PETER CDirectorNov 06Option Exercise27.5820,000551,600314,800Nov 08 04:28 PM
FARRELL PETER CDirectorNov 06Sale83.5320,0001,670,580294,800Nov 08 04:28 PM
PENDARVIS DAVIDChief Administrative OfficerNov 03Option Exercise27.586,364175,519100,748Nov 06 02:47 PM
PENDARVIS DAVIDChief Administrative OfficerNov 03Sale82.206,364523,12194,384Nov 06 02:47 PM
Sandercock BrettChief Financial OfficerNov 01Sale84.501,250105,62571,772Nov 02 07:12 PM
Farrell Michael J.Chief Executive OfficerOct 31Option Exercise33.703,300111,210232,732Nov 01 07:50 PM
FARRELL PETER CDirectorOct 04Option Exercise27.5820,000551,600314,800Oct 06 12:54 PM
FARRELL PETER CDirectorOct 04Sale77.0120,0001,540,200294,800Oct 06 12:54 PM
PENDARVIS DAVIDChief Administrative OfficerOct 03Option Exercise27.586,364175,51993,172Oct 05 12:49 PM
PENDARVIS DAVIDChief Administrative OfficerOct 03Sale76.946,364489,64686,808Oct 05 12:49 PM
Sandercock BrettChief Financial OfficerOct 02Sale77.051,25096,31364,691Oct 03 05:54 PM
ROBERTS CHRISTOPHER GDirectorSep 29Option Exercise38.9825,9341,010,907224,337Oct 03 12:42 PM
PENDARVIS DAVIDChief Administrative OfficerSep 05Option Exercise27.586,364175,51993,172Sep 06 04:13 PM
FARRELL PETER CDirectorSep 05Option Exercise27.5820,000551,600314,800Sep 06 05:55 PM
PENDARVIS DAVIDChief Administrative OfficerSep 05Sale77.216,364491,36486,808Sep 06 04:13 PM
FARRELL PETER CDirectorSep 05Sale76.7420,0001,534,797294,800Sep 06 05:55 PM
Sandercock BrettChief Financial OfficerSep 01Sale77.561,25096,95065,941Sep 05 11:45 AM
SULPIZIO RICHARDDirectorAug 09Option Exercise33.7024,390821,94328,819Aug 11 02:33 PM
SULPIZIO RICHARDDirectorAug 09Sale73.8524,3901,801,2024,429Aug 11 02:33 PM
FARRELL PETER CDirectorAug 04Option Exercise27.5820,000551,600321,557Aug 07 05:25 PM
FARRELL PETER CDirectorAug 04Sale75.1520,0001,503,000301,557Aug 07 05:25 PM
PENDARVIS DAVIDChief Administrative OfficerAug 03Option Exercise27.586,364175,51984,476Aug 04 04:08 PM
PENDARVIS DAVIDChief Administrative OfficerAug 03Sale72.106,364458,84478,112Aug 04 04:08 PM
Sandercock BrettChief Financial OfficerAug 01Sale77.491,25096,86359,258Aug 01 09:16 PM
Hollingshead JamesPresident, AmericasJul 14Option Exercise43.635,265229,71243,358Jul 17 01:59 PM
Hollingshead JamesPresident, AmericasJul 14Sale77.437,140552,85036,218Jul 17 01:59 PM
FARRELL PETER CDirectorJul 05Option Exercise27.5820,000551,600321,557Jul 06 06:13 PM
FARRELL PETER CDirectorJul 05Sale76.5020,0001,530,064301,557Jul 06 06:13 PM
PENDARVIS DAVIDChief Administrative OfficerJul 03Option Exercise27.586,364175,51984,476Jul 05 03:04 PM
Sandercock BrettChief Financial OfficerJul 03Sale77.441,25096,80060,508Jul 05 06:56 PM
PENDARVIS DAVIDChief Administrative OfficerJul 03Sale77.366,364492,31978,112Jul 05 03:04 PM
SULPIZIO RICHARDDirectorJun 22Sale77.8265,8875,127,2600Jun 27 07:34 PM
PACE GARY WDirectorJun 15Option Exercise33.7022,660763,642120,247Jun 16 11:20 AM
PACE GARY WDirectorJun 15Sale76.0022,6601,722,16097,587Jun 16 11:20 AM
PACE GARY WDirectorJun 14Option Exercise33.701,73058,30199,317Jun 16 11:20 AM
PACE GARY WDirectorJun 14Sale76.001,730131,48097,587Jun 16 11:20 AM
PENDARVIS DAVIDChief Administrative OfficerJun 05Option Exercise27.586,365175,54784,477Jun 06 02:11 PM
FARRELL PETER CDirectorJun 05Option Exercise27.5820,000551,600321,557Jun 06 02:44 PM
FARRELL PETER CDirectorJun 05Sale72.6520,0001,452,960301,557Jun 06 02:44 PM
PENDARVIS DAVIDChief Administrative OfficerJun 05Sale72.626,365462,22678,112Jun 06 02:11 PM
Sandercock BrettChief Financial OfficerJun 01Sale71.021,25088,77561,758Jun 05 01:12 PM
FARRELL PETER CDirectorMay 04Option Exercise27.5820,000551,600321,557May 05 12:38 PM
FARRELL PETER CDirectorMay 04Sale68.7520,0001,374,920301,557May 05 12:38 PM
PENDARVIS DAVIDChief Administrative OfficerMay 03Option Exercise27.586,365175,54784,261May 05 11:58 AM
PENDARVIS DAVIDChief Administrative OfficerMay 03Sale69.556,365442,67977,896May 05 11:58 AM
Sandercock BrettChief Financial OfficerMay 01Sale68.601,25085,75062,783May 03 01:25 PM
ROBERTS CHRISTOPHER GDirectorApr 24Option Exercise30.4152,7931,605,298198,403Apr 25 07:16 PM
Hollingshead JamesPresident, AmericasApr 17Option Exercise43.635,264229,66844,934Apr 18 02:55 PM
Hollingshead JamesPresident, AmericasApr 17Sale68.377,139488,09337,795Apr 18 02:55 PM
FARRELL PETER CDirectorApr 04Option Exercise27.5820,000551,600321,557Apr 06 01:14 PM
FARRELL PETER CDirectorApr 04Sale70.6720,0001,413,360301,557Apr 06 01:14 PM
PENDARVIS DAVIDChief Administrative OfficerApr 03Option Exercise27.586,365175,54784,261Apr 04 05:58 PM
Sandercock BrettChief Financial OfficerApr 03Sale71.651,25089,56364,033Apr 04 07:52 PM
PENDARVIS DAVIDChief Administrative OfficerApr 03Sale71.596,365455,64577,896Apr 04 05:58 PM
FARRELL PETER CDirectorMar 06Option Exercise32.5020,000650,040321,557Mar 08 03:51 PM
FARRELL PETER CDirectorMar 06Sale71.7020,0001,434,000301,557Mar 08 03:51 PM
PENDARVIS DAVIDChief Administrative OfficerMar 03Option Exercise27.586,365175,54784,261Mar 06 04:02 PM
PENDARVIS DAVIDChief Administrative OfficerMar 03Sale72.226,365459,68077,896Mar 06 04:02 PM
Sandercock BrettChief Financial OfficerMar 01Sale72.481,25090,60065,283Mar 02 09:57 PM
ROBERTS CHRISTOPHER GDirectorFeb 22Sale72.1015,0001,081,500298,900Feb 24 03:22 PM
ROBERTS CHRISTOPHER GDirectorFeb 20Sale71.9110,000719,100313,900Feb 21 02:11 PM
FARRELL PETER CDirectorFeb 06Option Exercise33.7020,000674,000321,557Feb 07 03:14 PM
FARRELL PETER CDirectorFeb 06Sale68.3220,0001,366,420301,557Feb 07 03:14 PM
PENDARVIS DAVIDChief Administrative OfficerFeb 03Option Exercise27.586,365175,54784,261Feb 06 03:22 PM
PENDARVIS DAVIDChief Administrative OfficerFeb 03Sale67.166,365427,47377,896Feb 06 03:22 PM
Hollingshead JamesPresident, AmericasJan 17Option Exercise43.635,264229,66846,754Jan 19 05:22 PM
Hollingshead JamesPresident, AmericasJan 17Sale64.447,084456,49339,670Jan 19 05:22 PM
FARRELL PETER CDirectorJan 04Option Exercise33.7020,000674,000321,557Jan 05 05:24 PM
FARRELL PETER CDirectorJan 04Sale62.1420,0001,242,760301,557Jan 05 05:24 PM
PENDARVIS DAVIDChief Administrative OfficerJan 03Option Exercise27.586,365175,54784,261Jan 04 04:01 PM
PENDARVIS DAVIDChief Administrative OfficerJan 03Sale61.956,365394,31277,896Jan 04 04:01 PM
FARRELL PETER CDirectorDec 05Option Exercise33.7020,000674,000372,407Dec 06 04:49 PM
PENDARVIS DAVIDChief Administrative OfficerDec 05Option Exercise27.586,365175,54784,261Dec 06 04:50 PM
PENDARVIS DAVIDChief Administrative OfficerDec 05Sale60.006,365381,90077,896Dec 06 04:50 PM
FARRELL PETER CDirectorDec 05Sale59.8320,0001,196,540352,407Dec 06 04:49 PM